Reply to: "Experimental aspects of copy number variant assays at CCL3L1".
He
Weijing
W
Kulkarni
Hemant
H
Castiblanco
John
J
Shimizu
Chisato
C
Aluyen
Una
U
Maldonado
Robert
R
Carrillo
Andrew
A
Griffin
Madeline
M
Lipsitt
Amanda
A
Beachy
Lisa
L
Shostakovich-Koretskaya
Ludmila
L
Mangano
Andrea
A
Sen
Luisa
L
Nibbs
Robert J B
RJ
Tiemessen
Caroline T
CT
Bolivar
Hector
H
Bamshad
Michael J
MJ
Clark
Robert A
RA
Burns
Jane C
JC
Dolan
Matthew J
MJ
Ahuja
Sunil K
SK
D000163:Acquired Immunodeficiency Syndrome / Q000235:genetics; D000465:Algorithms; D023241:Antiretroviral Therapy, Highly Active; D001681:Biological Assay; D016022:Case-Control Studies; D019742:Chemokines, CC / Q000032:analysis* / Q000235:genetics; D002886:Chromosomes, Human, Pair 17; D002893:Chromosomes, Human, Pair 3; D016000:Cluster Analysis; D015331:Cohort Studies; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D015342:DNA Probes / Q000737:chemistry; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics; D018450:Disease Progression; D005006:Ethnicity / Q000235:genetics; D018628:Gene Dosage; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D008024:Ligands; D016133:Polymerase Chain Reaction / Q000379:methods; D044382:Population Groups / Q000235:genetics; D019713:Receptors, CCR5 / Q000235:genetics; D012015:Reference Standards; D015203:Reproducibility of Results; D020079:Terminal Repeat Sequences / Q000235:genetics; D006113:United Kingdom
C492767:CCL3L1 protein, human; C492768:CCL4L1 protein, human; D019742:Chemokines, CC; D015342:DNA Probes; D008024:Ligands; D019713:Receptors, CCR5; D004247:DNA